Literature DB >> 18280210

The global burden and stigma of epilepsy.

Hanneke M de Boer1, Marco Mula, Josemir W Sander.   

Abstract

Epilepsy is one of the most prevalent neurological conditions and it knows no age, racial, social class, geographic, or national boundaries. The impact of epilepsy rests not only on the individual patient, but also on the family and indirectly on the community. The burden of epilepsy may be due to the physical hazards of epilepsy resulting from the unpredictability of seizures; the social exclusion as a result of negative attitudes of others toward people with epilepsy; and the stigma, as children with epilepsy may be banned from school, adults may be barred from marriage, and employment is often denied, even when seizures would not render the work unsuitable or unsafe. Furthermore, epilepsy is a disorder associated with significant psychological consequences, with increased levels of anxiety, depression, and poor self-esteem compared with people without this condition. Here we discuss some of the aspects of the global burden of epilepsy.

Entities:  

Mesh:

Year:  2008        PMID: 18280210     DOI: 10.1016/j.yebeh.2007.12.019

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  131 in total

Review 1.  Global disparities in the epilepsy treatment gap: a systematic review.

Authors:  Ana-Claire Meyer; Tarun Dua; Juliana Ma; Shekhar Saxena; Gretchen Birbeck
Journal:  Bull World Health Organ       Date:  2009-09-25       Impact factor: 9.408

2.  Lateralization of temporal lobe epilepsy using resting functional magnetic resonance imaging connectivity of hippocampal networks.

Authors:  Victoria L Morgan; Hasan H Sonmezturk; John C Gore; Bassel Abou-Khalil
Journal:  Epilepsia       Date:  2012-07-10       Impact factor: 5.864

Review 3.  Epilepsy in 2015: Classic antiepileptic drugs under fire, and new options emerge.

Authors:  Christian E Elger
Journal:  Nat Rev Neurol       Date:  2016-01-22       Impact factor: 42.937

Review 4.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 5.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 6.  Is epilepsy a preventable disorder? New evidence from animal models.

Authors:  Kathryn A Giblin; Hal Blumenfeld
Journal:  Neuroscientist       Date:  2010-06       Impact factor: 7.519

7.  Transplantation of GABAergic Interneurons into the Neonatal Primary Visual Cortex Reduces Absence Seizures in Stargazer Mice.

Authors:  Mohamed Hammad; Stephen L Schmidt; Xuying Zhang; Ryan Bray; Flavio Frohlich; H Troy Ghashghaei
Journal:  Cereb Cortex       Date:  2014-05-08       Impact factor: 5.357

8.  Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.

Authors:  Jacklyn A Harris; Julie A Murphy
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

9.  Stigma as a fundamental cause of population health inequalities.

Authors:  Mark L Hatzenbuehler; Jo C Phelan; Bruce G Link
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

10.  Alexithymia and posttraumatic stress disorder following epileptic seizure.

Authors:  Man Cheung Chung; Rachel D Allen
Journal:  Psychiatr Q       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.